Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 3.88B | 3.88B | 3.94B | 3.78B | 3.61B | 2.91B |
Gross Profit | 1.50B | 1.50B | 1.59B | 1.31B | 1.31B | 1.05B |
EBITDA | 844.73M | 902.60M | 976.07M | 934.24M | 844.20M | 594.80M |
Net Income | 424.00M | 424.00M | 510.20M | 512.00M | 459.10M | 262.80M |
Balance Sheet | ||||||
Total Assets | 5.23B | 5.23B | 4.91B | 4.48B | 4.24B | 4.09B |
Cash, Cash Equivalents and Short-Term Investments | 562.70M | 562.70M | 365.00M | 113.00M | 125.00M | 208.50M |
Total Debt | 1.21B | 1.21B | 1.20B | 1.14B | 955.50M | 922.60M |
Total Liabilities | 3.07B | 3.07B | 3.05B | 2.87B | 2.91B | 3.03B |
Stockholders Equity | 2.16B | 2.16B | 1.86B | 1.61B | 1.33B | 1.06B |
Cash Flow | ||||||
Free Cash Flow | 374.35M | 380.60M | 464.90M | 7.80M | 497.50M | 666.70M |
Operating Cash Flow | 802.80M | 802.80M | 914.20M | 607.60M | 757.20M | 786.90M |
Investing Cash Flow | -446.70M | -446.70M | -470.50M | -660.10M | -348.20M | -120.40M |
Financing Cash Flow | -165.90M | -165.90M | -210.10M | -25.40M | -449.60M | -540.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | £74.56B | 23.17 | 15.22% | 1.29% | 3.85% | -0.93% | |
78 Outperform | $36.76B | 33.77 | 12.10% | 0.52% | 1.02% | -45.31% | |
76 Outperform | $38.53B | 40.76 | 11.89% | 0.67% | 0.19% | 4.33% | |
75 Outperform | $12.94B | 8.31 | 7.12% | 0.98% | -9.62% | 795.20% | |
74 Outperform | $7.58B | 17.20 | 31.87% | 0.43% | 0.88% | -4.17% | |
72 Outperform | $17.22B | 29.63 | 21.09% | ― | -1.59% | -15.58% | |
58 Neutral | HK$18.72B | 4.84 | -7.29% | 3.76% | -4.22% | -42.85% |